Zurueck zur Suche

Reporte zur Charge UJ906AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 3 IN 2 NY 1 MD 1 CA 1 VA 1

VAERS 2524106

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

mild
Staat
NY
Alter
4,0
Geschlecht
M
Eingang
06.12.2022
Impfdatum
03.12.2022
Beginn
03.12.2022
Tage bis Beginn
0,0
Dosis
6
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Rash erythematous Rash macular Urinary incontinence Vomiting

Symptomtext

Patient immediately developed red blotchy diffuse rash; Vomited. Had urinary incontinence. No LOC. VS remained normal. Was given 25mg of po Benadryl. No epi was given. Patient was observed for over 30 minutes and symptoms resolved. Phone follow-up later in day: patient was doing well with no symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Vitamins ACD
Allergien
None known
Vorherige Impfungen
-

VAERS 2505756

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

mild
Staat
MD
Alter
63,0
Geschlecht
M
Eingang
11.11.2022
Impfdatum
31.10.2022
Beginn
31.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site vesicles Injection site warmth Pain in extremity

Symptomtext

Moderna COVID-19 Vaccine, Bivalent EUA COPY/PASTE of visit note with provider 11/08/22: Pt presents for evaluation of left upper arm swelling, blistering and redness, which he noticed the day after he received both his bivalent COVID booster and the flu shot in the left deltoid. He requested that the vaccines be given in the same arm so he would have one good arm as he is the caregiver for his 93-year old mom. His arm felt sore within hours of the vaccine, but he did not examine the site. The following day, the soreness was worse and he observed redness, swelling, warmth and a large blister. He took no measures to treat this. The blistering resolved and now it looks like a burn. It feels like a burn. There is no deep pain or arm weakness. He has not experienced fever.or chills.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
COPY/PASTE of visit note 11/08/22: Diagnoses and all orders for this visit: Vaccine reaction, initial encounter Comments: hypersensitivity reaction, local - use triamcinolone ointment tid and silvadene bid Orders: - triamcinolone (ARISTOCORT) 0.1 % topical ointment; Apply topically 3 (three) times daily. - silver sulfADIAZINE (SILVADENE) 1 % topical cream; Apply topically 2 (two) times daily. Blistering of skin Comments: hypersensitivity reaction, local - use triamcinolone ointment tid and silvadene bid Orders: - triamcinolone (ARISTOCORT) 0.1 % topical ointment; Apply topically 3 (three) times daily. - silver sulfADIAZINE (SILVADENE) 1 % topical cream; Apply topically 2 (two) times daily.
Aktuelle Erkrankungen
Dizziness X 1 month prior to vaccination. Reason for visit on 10/31/22 was dizziness
Vorgeschichte
Borderline HTN noted 08/2014 OA of knee noted 09/2014 BPH noted 07/2016 Panic Disorder noted 02/2018 Claustrophobia noted 10/2020
Andere Medikamente
Amoxicillin X 7 days prescribed 10/05/22 for dizziness- completed Prednisone X 10 days prescribed 10/11/22 for dizziness- completed Augmentin X 14 days prescribed 10/14/22 for dizziness- completed
Allergien
none
Vorherige Impfungen
-

VAERS 2626999

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UJ906AA

gering
Staat
CA
Alter
21,0
Geschlecht
F
Eingang
05.05.2023
Impfdatum
28.04.2023
Beginn
28.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Maternal exposure during pregnancy

Symptomtext

vaccine given to 27 weeks pregnant patient with no reported adverse event; Initial information received on 01-May-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 21 years old female patient who was exposed to vaccine influenza usp trival a-b subvirion no preservative vaccine [fluzone] in context of vaccine given to 27 weeks pregnant patient with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported vaccine given to 27 weeks pregnant patient with no reported adverse event occurred at 27 weeks of pregnancy and the patient was exposed to Influenza usp trival a-b subvirion no preservative vaccine at 27 weeks of pregnancy, during third pregnancy trimester for influenza usp trival a-b subvirion no preservative vaccine. The date of last menstrual period was reported as 23-Oct-2022. The estimated due date is 30-Jul-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 28-Apr-2023, the patient received 0.5 ml of suspect influenza usp trival a-b subvirion no preservative vaccine Suspension for injection lot UJ906AA, 30-Jun-2023 via intramuscular route in the left deltoid for Influenza. On 28-Apr-2023 the patient developed a non-serious vaccine given to 27 weeks pregnant patient with no reported adverse event (exposure during pregnancy) (latency: same day). Relevant prenatal testing after exposure was unknown Lab data was not reported. Action taken was not applicable. Outcome: Unknown for the event vaccine given to 27 weeks pregnant patient with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Maternal exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574314

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

gering
Staat
VA
Alter
12,0
Geschlecht
F
Eingang
02.02.2023
Impfdatum
01.01.2023
Beginn
01.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Claritin
Allergien
Amoxicillin, Peanuts, Hazelnuts
Vorherige Impfungen
-

VAERS 2563494

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

gering
Staat
MI
Alter
11,0
Geschlecht
M
Eingang
19.01.2023
Impfdatum
19.01.2023
Beginn
19.01.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event Wrong patient received product Wrong product administered

Symptomtext

Vaccinations were drawn for patient and sibling. Patient received 2 influenza vaccines (his and sibling's) instead of his MenQuadFi when administering. Patient was observed for 15 minutes with no adverse reaction. Mother was notified and patient did receive correct vaccine at this visit. Mother aware to call with any concerns and advised on what to watch for, and she voiced understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Celiac's disease
Andere Medikamente
Pediatric multivitamin
Allergien
Gluten (Celiac) and amoxicillin
Vorherige Impfungen
-

VAERS 2521906

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

gering
Staat
MI
Alter
1,3
Geschlecht
M
Eingang
02.12.2022
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

none

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Covid and Flu
Vorgeschichte
NA
Andere Medikamente
Kenalog Cream
Allergien
NKA
Vorherige Impfungen
-

VAERS 2519964

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

gering
Staat
MI
Alter
5,0
Geschlecht
M
Eingang
30.11.2022
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect product formulation administered No adverse event

Symptomtext

Covid Bilvalent 5-11 vaccine was given as first dose of COVID vaccine. Monovalent version should have been given. No adverse reactions in office. Pt was monitored for 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2509696

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ906AA

gering
Staat
IN
Alter
63,0
Geschlecht
F
Eingang
16.11.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect route of product administration Needle issue No adverse event

Symptomtext

In drawing multiple doses from the above multi-dose vial, this RN mistakenly attached 25g, 5/8" needles instead of the necessary 1" to 1 1/2" length. This means this client received a subcutaneous injection instead of the required intramuscular. This error involved two clients before it was caught. Both clients were called, no adverse effects were noted. Repeat influenza vaccine given today and charted. Will continue to monitor for any reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
None at this time.
Aktuelle Erkrankungen
Schizophrenia
Vorgeschichte
Schizophrenia
Andere Medikamente
Lithium
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 2509690

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge UJ906AA

gering
Staat
IN
Alter
83,0
Geschlecht
F
Eingang
16.11.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration Needle issue

Symptomtext

When drawing up several doses of the above vaccine from a multi-dose vial, I attached 25g, 5/8" needles instead of 1-1 1/2" needles. 2 injections were given with the sub-Q needles. The error was noted within 5 minutes of the 2nd injection. Both clients were called and a second flu vaccine was given today, 11/16/2022. Both clients denied any side effects from the initial injection. This nurse will follow up via phone on 11/17/2022 to again evaluate any adverse reactions. Syringes/needles have been re-labeled as well as re-education to all staff.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
None at present time.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Morphine
Vorherige Impfungen
-